HCI Group, Inc.

**Signal Note: Driehaus Capital initiates $66.4M position in HCI Group** This signals notable conviction from a growth-focused allocator, though HCI Group is primarily a property & casualty insurer with no significant biotech operations—suggesting either a data error or a non-core portfolio diversification move. If this reflects actual biotech exposure, clarification on the underlying asset or subsidiary investment would be required to assess clinical/commercial catalysts.